RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
#ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patients with cancer @mini_kamboj @yingtaur @tmhohl71 & co #COVID19 https://t.co/Cj9TMaN99X
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @CHM_MSKCC: Great summary of the early #COVID19 experience in #Cancer patients @sloan_kettering
Determinantes de la gravedad de la enfermedad #COVID-19 en pacientes con #Cáncer Descubre los factores asociados con la gravedad de la enfermedad y las interacciones con las terapias contra el cáncer. https://t.co/Xxo3AIfaop https://t.co/M28p6pLKAN
Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/HaD0HMuSYY
RT @SaheliSadanand: Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @…
RT @LujanPomponio: Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/NUbIUBfHvY
Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/NUbIUBfHvY
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @nresearchnews: A paper in @NatureMedicine suggests that advanced cancer, receipt of chemotherapy and recent cancer surgery might not ex…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @SaheliSadanand: Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
Important thread. #covid19 #CancerResearch
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @SaheliSadanand: Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @SaheliSadanand: Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @sloan_kettering #COVID19nCancer
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @DanielJDrucker: Spoiler alert. There will be few chronic illnesses, including those characterized by immunosuppression, that are not as…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @MuinJKhoury: What determines #COVID19 disease severity in patients with cancer? Via @NatureMedicine https://t.co/poBJ4w4ovF https://t.c…
Great study from our MSKCC colleagues “Age older than 65 years and treatment with immune checkpoint inhibitors (ICIs) were predictors for hospitalization and severe disease, whereas receipt of chemotherapy and major surgery were not. “ https://t.co/YGZl1yX
What determines #COVID19 disease severity in patients with cancer? Via @NatureMedicine https://t.co/poBJ4w4ovF https://t.co/Yat6cItsgn
RT @mini_kamboj: Great summary of the @sloan_kettering early COVID-19 experience now published in @NatureMedicine
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @CHM_MSKCC: Great summary of the early #COVID19 experience in #Cancer patients @sloan_kettering https://t.co/BR72sehY3g
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @BeckiLee: MSKCC experience of cancer patients and COVID- 19 - the IO data does not match our experience in a large tertiary centre trea…
MSKCC experience of cancer patients and COVID- 19 - the IO data does not match our experience in a large tertiary centre treating a huge number of patients with IO during pandemic- we had many less cases of COVID-19 but difference is still hard to explain
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
These are the kind of studies that are lacking in #COVID19. Determining risk factors. In this case, patients undergoing cancer treatment with immune checkpoint inhibitors were more at risk for aggravated disease than patients on chemo https://t.co/wWsb1ede
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
Important analysis and some caution with respect to ICI treatment in the elderly cancer patients may be warranted in regions with high COVID-19 prevalence.
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine. @yingtaur @mini_kamboj @tmhohl71 @EBabady @evrnyc @meadp1 @T19R84…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
🚨 New MSK study published today in @NatureMedicine. @yingtaur @mini_kamboj @tmhohl71 @EBabady @evrnyc @meadp1 @T19R84 @MichaelGlickma1 @wolchokj #COVID19 #sarscov2
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors associated with disease severity and interactions with anti-cancer therapies. @mini_kamboj @yingtaur @sloan_kettering #cancer #SARSCoV2 http
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @mini_kamboj: Great summary of the @sloan_kettering early COVID-19 experience now published in @NatureMedicine https://t.co/854qmB9oBQ
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
Great summary of the @sloan_kettering early COVID-19 experience now published in @NatureMedicine
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: Great thread from @tmhohl71 on new MSK study published today in @NatureMedicine. #COVID19 @mini_kamboj @EBabady @evrny…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @NBSaphierMD: 💙
RT @NBSaphierMD: 💙
After reassuring news earlier this week, worries about #immunotherapy during #COVID19 are once again raised. However _many_ potential confounders driven by overweight of pts with lung cancer in ICI cohort (copd, RT, smoking). Would like to see data from
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: Great thread from @tmhohl71 on new MSK study published today in @NatureMedicine. #COVID19 @mini_kamboj @EBabady @evrny…
💙
Great thread from @tmhohl71 on new MSK study published today in @NatureMedicine. #COVID19 @mini_kamboj @EBabady @evrnyc @yingtaur @meadp1 @T19R84 @MichaelGlickma1 @wolchokj
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https://t.co/yaWnqoetdc
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer patients treated at our institution. What did we find? https://t.co/yR7uDTr6oY
RT @DanielJDrucker: Spoiler alert. There will be few chronic illnesses, including those characterized by immunosuppression, that are not as…
#cancer and #COVID19: double bad news... https://t.co/JzpQDhawR5
Spoiler alert. There will be few chronic illnesses, including those characterized by immunosuppression, that are not associated with increased #COVID19 morbidity & mortality @NatureMedicine https://t.co/PN7oUgDe5B